BRIEF published on 12/23/2024 at 21:09, 1 year 5 months ago Succès de l'offre publique de TME Pharma N.V. Actionnaires Augmentation De Capital Cancer NOX-A12 Stratégies Financières
BRIEF published on 12/23/2024 at 21:09, 1 year 5 months ago Successful public offering of TME Pharma NV Shareholders Capital Increase Cancer Financial Strategies NOX-A12
PRESS RELEASE published on 12/23/2024 at 21:04, 1 year 5 months ago Informations privilégiées / Autres communiqués TME Pharma réussit son offre publique de 2,6 millions d'euros, renforçant sa position financière jusqu'en juin 2025. Les actionnaires soutiennent la levée de fonds pour NOX-A12 et NOX-E36 Augmentation De Capital Offre Publique TME Pharma NOX-A12 NOX-E36
BRIEF published on 12/04/2024 at 19:55, 1 year 6 months ago TME Pharma annonce une mise à jour stratégique et un plan de financement de 2,6 millions d'euros Stratégie D'entreprise Offre Publique Plan De Financement Développement Du NOX-A12 Priorité Aux Actionnaires
BRIEF published on 12/04/2024 at 19:55, 1 year 6 months ago TME Pharma Announces Strategic Update and €2.6 Million Financing Plan Public Offer Corporate Strategy Financing Plan NOX-A12 Development Shareholder Priority
PRESS RELEASE published on 12/04/2024 at 19:50, 1 year 6 months ago Informations privilégiées / Autres communiqués TME Pharma annonce une nouvelle stratégie et un financement garanti de 2,6 millions d'euros pour ses projets NOX-A12 et NOX-E36 jusqu'en juin 2025 Financement Offre Publique TME Pharma NOX-A12 NOX-E36
PRESS RELEASE published on 12/04/2024 at 19:50, 1 year 6 months ago Inside Information / Other news releases TME Pharma announces corporate strategy update with upcoming €2.6 million financing aimed at further developing therapies for cancer treatment through public offer open to shareholders. CEO Mangasarian highlights strategic goals and plans Financing Cancer Treatment Public Offer Corporate Strategy TME Pharma
BRIEF published on 11/23/2024 at 10:59, 1 year 6 months ago TME Pharma présente ses résultats sur NOX-A12 dans le glioblastome Thérapie Contre Le Cancer Glioblastome NOX-A12 Inhibition Du Point De Contrôle Immunitaire Microenvironnement Tumoral
BRIEF published on 11/23/2024 at 10:59, 1 year 6 months ago TME Pharma Presents Findings on NOX-A12 in Glioblastoma Cancer Therapy Glioblastoma NOX-A12 Immune Checkpoint Inhibition Tumor Microenvironment
PRESS RELEASE published on 11/23/2024 at 10:54, 1 year 6 months ago Informations privilégiées / Autres communiqués TME Pharma annonce la présentation d'un poster par le National Cancer Institute américain sur l'inhibition de CXCL12 par NOX-A12 dans le glioblastome à la réunion annuelle du SNO 2024 Glioblastome TME Pharma NOX-A12 National Cancer Institute Inhibition
Published on 06/06/2026 at 04:45, 1 day 22 hours ago Battery X Metals Announces Closing of First Tranche of Private Placement to Advance Corporate Growth
Published on 06/06/2026 at 00:00, 2 days 3 hours ago Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 2 days 10 hours ago Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 2 days 12 hours ago Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 2 days 14 hours ago CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/07/2026 at 21:24, 6 hours 8 minutes ago EQS-Adhoc: Readcrest Capital AG: Management Board issues forecast for adjusted EBITDA in 2026
Published on 06/07/2026 at 18:53, 8 hours 38 minutes ago Marley Spoon Group SE: Successful refinancing and leadership transition
Published on 06/07/2026 at 18:40, 8 hours 51 minutes ago EQS-Adhoc: Marley Spoon Group SE: CEO Resigns; Interim CEO Appointed
Published on 06/07/2026 at 10:55, 16 hours 36 minutes ago Bybit Launches IPO Express, Becoming One of First Centralized Crypto Exchanges to Offer Tokenized IPO Access, Starting With SpaceX
Published on 06/06/2026 at 08:29, 1 day 19 hours ago Starting today, Trade Republic gives European retail investors direct access to IPOs
Published on 06/05/2026 at 19:00, 2 days 8 hours ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 2 days 8 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 2 days 8 hours ago ALTAREIT - Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 2 days 8 hours ago ALTAREA : Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 2 days 8 hours ago ALTAREIT - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MAI 2026
